Algernon Pharmaceuticals Inc (QB) (AGNPF) Fundamentals

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Share Info
Market Cap$ 5,979,279
Shares Authorized-
Shares Outstanding1,674,868
Shares Outstanding Date06/30/2021
Shareholder Count-
Shareholder Count Date-
Float Date01/07/2022
Short Interest25,845
Short Interest Date06/30/2021
Reporting Info
Reporting StatusInternational Reporting
Audit StatusYes
AuditorSmythe LLP
Auditor Address1700 - 475 Howe Street
Vancouver, British Columbia V6C 2B3
Auditor Websitehttp://
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselMcMillan LLP
Legal Counsel AddressRoyal Centre, 1055 W. Georgia Street,
Suite 1500
Vancouver, British Columbia V6E 4N7
Legal Counsel Website
Fiscal Year End8/31
ADR Ratio-
Transfer AgentAST Trust Company Canada
Transfer Agent Address2001 Boul. Robert-Bourassa
Suite 1600
Montreal, QC H3A 2A6
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:AGNPF
OTC Market TierOTCQB
Security TypeOrdinary Shares
CIK Number0001642178
AddressSuite 1500 - 1055 West Georgia Street
Vancouver, British Columbia V6E 4N7
Fax #-
SIC Code / Description9999 / Nonclassifiable establishments
Key ExecutivesVice President - Christopher Bryan
CEO - Christopher Moreau
Dir. - Mark Williams
Chairman - Harry Bloomfield
CFO - James Kinley
Dir. - Raj Attariwala
Dir. - David Levine
Number of Employees4
Incorporation StateBritish Columbia
Incorporation CountryCanada
Incorporation Year2015

Your Recent History
Algernon P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.